1. Home
  2. IZM vs SCYX Comparison

IZM vs SCYX Comparison

Compare IZM & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IZM
  • SCYX
  • Stock Information
  • Founded
  • IZM 2011
  • SCYX 1999
  • Country
  • IZM China
  • SCYX United States
  • Employees
  • IZM N/A
  • SCYX N/A
  • Industry
  • IZM Consumer Electronics/Video Chains
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IZM Consumer Discretionary
  • SCYX Health Care
  • Exchange
  • IZM Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • IZM 31.8M
  • SCYX 32.3M
  • IPO Year
  • IZM 2023
  • SCYX 2014
  • Fundamental
  • Price
  • IZM $1.38
  • SCYX $0.60
  • Analyst Decision
  • IZM
  • SCYX Strong Buy
  • Analyst Count
  • IZM 0
  • SCYX 1
  • Target Price
  • IZM N/A
  • SCYX $3.00
  • AVG Volume (30 Days)
  • IZM 14.7K
  • SCYX 570.0K
  • Earning Date
  • IZM 10-24-2025
  • SCYX 11-05-2025
  • Dividend Yield
  • IZM N/A
  • SCYX N/A
  • EPS Growth
  • IZM N/A
  • SCYX N/A
  • EPS
  • IZM 0.10
  • SCYX N/A
  • Revenue
  • IZM $187,048,691.00
  • SCYX $2,932,000.00
  • Revenue This Year
  • IZM N/A
  • SCYX $368.39
  • Revenue Next Year
  • IZM N/A
  • SCYX $123.36
  • P/E Ratio
  • IZM $13.80
  • SCYX N/A
  • Revenue Growth
  • IZM 5.12
  • SCYX N/A
  • 52 Week Low
  • IZM $1.18
  • SCYX $0.58
  • 52 Week High
  • IZM $2.74
  • SCYX $1.49
  • Technical
  • Relative Strength Index (RSI)
  • IZM 12.22
  • SCYX 23.64
  • Support Level
  • IZM $1.36
  • SCYX $0.68
  • Resistance Level
  • IZM $1.58
  • SCYX $0.65
  • Average True Range (ATR)
  • IZM 0.13
  • SCYX 0.04
  • MACD
  • IZM -0.06
  • SCYX -0.01
  • Stochastic Oscillator
  • IZM 7.59
  • SCYX 5.83

About IZM ICZOOM Group Inc.

ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: